nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibody arrays: an embryonic but rapidly growing technology
|
Lal, Sean P. |
|
|
7 |
18 |
p. S143-S149 |
artikel |
2 |
Applications of transfected cell microarrays in high-throughput drug discovery
|
Bailey, Steve N. |
|
|
7 |
18 |
p. S113-S118 |
artikel |
3 |
Catalytic antioxidants prevent type 1 diabetes
|
Habeck, Martina |
|
|
7 |
18 |
p. 933-934 |
artikel |
4 |
Discovery informatics: its evolving role in drug discovery
|
Claus, Brian L. |
|
|
7 |
18 |
p. 957-966 |
artikel |
5 |
Emerging high-throughput drug target validation technologies
|
Ilag, Leodevico L. |
|
|
7 |
18 |
p. S136-S142 |
artikel |
6 |
Energy blocker to treat liver cancer
|
Foubister, Vida |
|
|
7 |
18 |
p. 934-935 |
artikel |
7 |
Erratum
|
Owens, J. |
|
|
7 |
18 |
p. 949 |
artikel |
8 |
Expanding the HTS paradigm
|
Inglese, James |
|
|
7 |
18 |
p. S105-S106 |
artikel |
9 |
From screen-saver to virtual screener: harnessing latent PC power through distributed computing
|
Good, Andrew |
|
|
7 |
18 |
p. 946-947 |
artikel |
10 |
High-throughput cell analysis using multiplexed array technologies
|
Beske, Oren E. |
|
|
7 |
18 |
p. S131-S135 |
artikel |
11 |
High-throughput cell-based assays in yeast
|
Tucker, Chandra L. |
|
|
7 |
18 |
p. S125-S130 |
artikel |
12 |
Identification of a protein tyrosine phosphatase 1B inhibitor with cellular activity
|
Langston, Steven |
|
|
7 |
18 |
p. 977-979 |
artikel |
13 |
In need of high-throughput behavioral systems
|
Brunner, Dani |
|
|
7 |
18 |
p. S107-S112 |
artikel |
14 |
LC/MS Applications in Drug Development
|
Vogel, Martin |
|
|
7 |
18 |
p. 950 |
artikel |
15 |
Monitor: Molecules and profiles
|
Barlocco, Daniela |
|
|
7 |
18 |
p. 976-977 |
artikel |
16 |
News in brief
|
Brown, M. |
|
|
7 |
18 |
p. 937-940 |
artikel |
17 |
Novel detection strategies for drug discovery
|
Hemmilä, Ilkka A. |
|
|
7 |
18 |
p. S150-S156 |
artikel |
18 |
People
|
Owens, Joanna |
|
|
7 |
18 |
p. 940 |
artikel |
19 |
Permeability issues in nasal drug delivery
|
Arora, Priyanka |
|
|
7 |
18 |
p. 967-975 |
artikel |
20 |
Predicting novel proteins and their interactions
|
Bajorath, Jürgen |
|
|
7 |
18 |
p. 945-946 |
artikel |
21 |
Prion vaccine: is there hope against CJD?
|
Roberts, Josh P. |
|
|
7 |
18 |
p. 936-937 |
artikel |
22 |
Should scientific innovation be managed?
|
Schmid, Esther F. |
|
|
7 |
18 |
p. 941-945 |
artikel |
23 |
Surrogate endpoints in cancer drug development
|
Sikora, Karol |
|
|
7 |
18 |
p. 951-956 |
artikel |
24 |
Systems biology: the new darling of drug discovery?
|
Werner, Eric |
|
|
7 |
18 |
p. 947-949 |
artikel |
25 |
The impact of protein biochips and microarrays on the drug development process
|
Huels, Christoph |
|
|
7 |
18 |
p. S119-S124 |
artikel |